Cargando…

Role of C-Reactive Protein in Contributing to Increased Cardiovascular Risk in Metabolic Syndrome

Metabolic syndrome is associated with increased propensity for diabetes and cardiovascular disease. Low-grade inflammation is characteristic of metabolic syndrome. C-reactive protein, the best characterized biomarker of inflammation, is also an independent predictor of future cardiovascular events....

Descripción completa

Detalles Bibliográficos
Autores principales:	Devaraj, Sridevi, Valleggi, Simona, Siegel, David, Jialal, Ishwarlal
Formato:	Texto
Lenguaje:	English
Publicado:	Current Science Inc. 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2854398/ https://www.ncbi.nlm.nih.gov/pubmed/20425246 http://dx.doi.org/10.1007/s11883-010-0098-3

Ejemplares similares

Statin Therapy in Metabolic Syndrome and Hypertension Post-JUPITER: What is the Value of CRP?
por: Devaraj, Sridevi, et al.
Publicado: (2010)

Dysfunctional Endothelial Progenitor Cells in Metabolic Syndrome
por: Devaraj, Sridevi, et al.
Publicado: (2012)

Increased Adipocyte Hypertrophy in Patients with Nascent Metabolic Syndrome
por: Jialal, Ishwarlal, et al.
Publicado: (2023)

Increased Toll-Like Receptor Activity in Patients With Metabolic Syndrome
por: Jialal, Ishwarlal, et al.
Publicado: (2012)

Comment on Lopes-Virella et al. Baseline Markers of Inflammation Are Associated With Progression to Macroalbuminuria in Type 1 Diabetic Subjects. Diabetes Care 2013;36:2317–2323
por: Jialal, Ishwarlal, et al.
Publicado: (2014)

AHA/ACC/Multisociety Cholesterol Guidelines: highlights
por: Jialal, Ishwarlal, et al.
Publicado: (2019)

Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects
por: Dasu, Mohan R., et al.
Publicado: (2010)

SAT-656 Both Neutrophil and Monocyte Ratios to High Density Lipoprotein Cholesterol Are Superior Biomarkers of Metabolic Syndrome
por: Ramakrishnan, Neeraj, et al.
Publicado: (2020)

High Glucose Induces Toll-Like Receptor Expression in Human Monocytes: Mechanism of Activation
por: Dasu, Mohan R., et al.
Publicado: (2008)

Adipose Tissue Dysfunction in Nascent Metabolic Syndrome
por: Bremer, Andrew A., et al.
Publicado: (2013)

Correlates of Insulin Resistance in Nascent Metabolic Syndrome
por: Adams-Huet, Beverley, et al.
Publicado: (2023)

Gut Microbiome and Inflammation: A Study of Diabetic Inflammasome-Knockout Mice
por: Pahwa, Roma, et al.
Publicado: (2017)

Bempedoic Acid, an Inhibitor of Cholesterol Biosynthesis, Reduces Cardiovascular Events
por: Jialal, Ishwarlal, et al.
Publicado: (2023)

Modulating inflammation to reduce atherosclerotic cardiovascular events: should colchicine be part of the therapeutic regimen?
por: Jialal, Ishwarlal, et al.
Publicado: (2021)

Exploratory metabolomics of metabolic syndrome: A status report
por: Lent-Schochet, Daniella, et al.
Publicado: (2019)

Hyperglycemia Induces Toll-Like Receptor-2 and -4 Expression and Activity in Human Microvascular Retinal Endothelial Cells: Implications for Diabetic Retinopathy
por: Rajamani, Uthra, et al.
Publicado: (2014)

Erratum to “Hyperglycemia Induces Toll-Like Receptor-2 and -4 Expression and Activity in Human Microvascular Retinal Endothelial Cells: Implications for Diabetic Retinopathy”
por: Rajamani, Uthra, et al.
Publicado: (2016)

Fetuin-A is also an adipokine
por: Jialal, Ishwarlal, et al.
Publicado: (2019)

Management of diabetic dyslipidemia: An update
por: Jialal, Ishwarlal, et al.
Publicado: (2019)

Management of Hypertriglyceridemia in the Diabetic Patient
por: Jialal, Ishwarlal, et al.
Publicado: (2010)

Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes
por: Devaraj, S., et al.
Publicado: (2009)

Use of Apolipoprotein B in the Era of Precision Medicine: Time for a Paradigm Change?
por: Cole, Justine, et al.
Publicado: (2023)

Natural and Synthetic Agents Targeting Reactive Carbonyl Species against Metabolic Syndrome
por: Behl, Tapan, et al.
Publicado: (2022)

The association of leptin and C-reactive protein with the cardiovascular risk factors and metabolic syndrome score in Taiwanese adults
por: Chiu, Feng-Hsiang, et al.
Publicado: (2012)

Metabolic syndrome, C-reactive protein and cardiovascular risk in psoriasis patients: a cross-sectional study
por: Paschoal, Renato Soriani, et al.
Publicado: (2018)

Metabolic syndrome and C-reactive protein in bank employees
por: Cattafesta, Monica, et al.
Publicado: (2016)

Impact of Time-Restricted Feeding and Dawn-to-Sunset Fasting on Circadian Rhythm, Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver Disease
por: Mindikoglu, Ayse L., et al.
Publicado: (2017)

Depression contributing to dyslipidemic cardiovascular risk in the metabolic syndrome
por: Lemche, A. V., et al.
Publicado: (2016)

Increased C-Reactive Protein in Brazilian Children: Association with Cardiometabolic Risk and Metabolic Syndrome Components (PASE Study)
por: Suhett, Lara Gomes, et al.
Publicado: (2019)

Analytical and clinical performance of cPass neutralizing antibodies assay
por: Jung, Joanna, et al.
Publicado: (2021)

The Role and Clinical Significance of High-Sensitivity C-Reactive Protein in Cardiovascular Disease
por: Seo, Hong Seog
Publicado: (2012)

Association between C-Reactive Protein and Metabolic Syndrome in Korean Adults
por: Song, Youhyun, et al.
Publicado: (2019)

Meta-Analysis on the Association of C-Reactive Protein Polymorphisms with Metabolic Syndrome
por: Sharafi, Seyedeh Maryam, et al.
Publicado: (2020)

High-Sensitivity C-Reactive Protein Relationship with Metabolic Disorders and Cardiovascular Diseases Risk Factors
por: Koziarska-Rościszewska, Małgorzata, et al.
Publicado: (2021)

Moderator role of vitamin D concentrations on the association between metabolic syndrome and C-reactive protein among adults
por: Fassula, Angelica Scherlowski, et al.
Publicado: (2020)

Insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein and metabolic syndrome
por: Wiwanitkit, Somsri, et al.
Publicado: (2011)

Association of Metabolic Syndrome and C-reactive Protein Levels with Intracranial Atherosclerotic Stroke
por: Bang, Oh Young, et al.
Publicado: (2005)

Lipoprotein (a), C-reactive protein and some metabolic cardiovascular risk factors in type 2 DM
por: Ogbera, Anthonia O, et al.
Publicado: (2010)

Comparison of random urine protein/creatinine ratio with 24-hour urine protein in suspected pre-eclampsia
por: Olayinka, Lily, et al.
Publicado: (2023)

The effect of four-week intermittent fasting from dawn to sunset on circulating brain-derived neurotrophic factor levels in subjects with metabolic syndrome and healthy subjects
por: Abdulsada, Mustafa M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a3685hiahihmvhdj3hev40opv5